Incorporation of unnatural nucleotides and methods thereof

US11834689B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11834689-B2
Application numberUS-202117196151-A
CountryUS
Kind codeB2
Filing dateMar 9, 2021
Priority dateJul 11, 2017
Publication dateDec 5, 2023
Grant dateDec 5, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

First claim

Opening claim text (preview).

What is claimed is: 1. A cell comprising: a. a nucleoside triphosphate transporter from Phaeodactylum tricornutum; b. a tRNA from Methanosarcina mazei or Methanococcus jannaschii comprising an anticodon, wherein the anticodon comprises a sequence selected from GGY, GYG, YGG, GAY, GYA, YGA, GCY, GYC, YGC, GUY, GYU, YGU, CAY, CYA, YCA, CGY, CYG, YCG, CUY, CYU, YCU, CCY, CYC, YCC, AAY, AYA, YAA, AGY, AYG, YAG, ACY, AYC, YAC, AUY, AYU, YAU, UUY, UYU, YUU, UAY, UYA, YUA, UGY, UYG, YUG, UCY, UYC, YUC, GYY, YGY, YYG, CYY, YCY, YYC, AYY, YAY, YYA, UYY, YUY, YYU, YYY, GGX, GXG, XGG, GAX, GXA, XGA, GCX, GXC, XGC, GUX, GXU, XGU, CAX, CXA, XCA, CGX, CXG, XCG, CUX, CXU, XCU, CCX, CXC, XCC, AAX, AXA, XAA, AGX, AXG, XAG, ACX, AXC, XAC, AUX, AXU, XAU, UUX, UXU, XUU, UAX, UXA, XUA, UGX, UXG, XUG, UCX, UXC, XUC, GXX, XGX, XXG, CXX, XCX, XXC, AXX, XAX, XXA, UXX, XUX, XXU, or XXX, and wherein each of Y and X are an unnatural nucleotide comprising an unnatural nucleobase selected from c. an aminoacyl tRNA synthetase from Methanosarcina or Methanococcus jannaschii ; and d. an mRNA comprising a codon, wherein the codon comprises a sequence selected from GGY, GYG, YGG, GAY, GYA, YGA, GCY, GYC, YGC, GUY, GYU, YGU, CAY, CYA, YCA, CGY, CYG, YCG, CUY, CYU, YCU, CCY, CYC, YCC, AAY, AYA, YAA, AGY, AYG, YAG, ACY, AYC, YAC, AUY, AYU, YAU, UUY, UYU, YUU, UAY, UYA, YUA, UGY, UYG, YUG, UCY, UYC, YUC, GYY, YGY, YYG, CYY, YCY, YYC, AYY, YAY, YYA, UYY, YUY, YYU, YYY, GGX, GXG, XGG, GAX, GXA, XGA, GCX, GXC, XGC, GUX, GXU, XGU, CAX, CXA, XCA, CGX, CXG, XCG, CUX, CXU, XCU, CCX, CXC, XCC, AAX, AXA, XAA, AGX, AXG, XAG, ACX, AXC, XAC, AUX, AXU, XAU, UUX, UXU, XUU, UAX, UXA, XUA, UGX, UXG, XUG, UCX, UXC, XUC, GXX, XGX, XXG, CXX, XCX, XXC, AXX, XAX, XXA, UXX, XUX, XXU, or XXX, and wherein each of Y and X are an unnatural nucleotide comprising an unnatural nucleobase selected from and wherein the anticodon of the tRNA pairs with the codon of the mRNA. 2. The cell of claim 1 , wherein the cell further comprises an oligonucleotide encoding the tRNA. 3. The cell of claim 1 , wherein the cell further comprises an oligonucleotide encoding the aminoacyl tRNA synthetase. 4. The cell of claim 1 , wherein the cell further comprises an oligonucleotide encoding the mRNA. 5. The cell of claim 1 , wherein the cell further comprises an oligonucleotide that encodes the tRNA and the mRNA. 6. The cell of claim 1 , wherein the cell further comprises an oligonucleotide that encodes the tRNA, the mRNA, and the aminoacyl tRNA synthetase. 7. The cell of claim 1 , wherein the unnatural nucleobase in the anticodon is and the unnatural nucleobase in the codon is 8. The cell of claim 7 , wherein the unnatural nucleobase in the codon is and the unnatural nucleobase in the anticodon is 9. The cell of claim 1 , wherein the anticodon comprises the sequence GYT or GYC, wherein Y comprises the unnatural nucleobase. 10. The cell of claim 9 , wherein the unnatural nucleobase of Y is 11. The cell of claim 10 , wherein the unnatural nucleobase of Y is 12. The cell of claim 10 , wherein the unnatural nucleobase of Y is 13. The cell of claim 1 , wherein the codon comprises the sequence AXC or GXC, wherein X comprises the unnatural nucleobase. 14. The cell of claim 13 , wherein the codon comprises the sequence AXC. 15. The cell of claim 14 , wherein the unnatural nucleobase of X is 16. The cell of claim 14 , wherein the unnatural nucleobase of X is 17. The cell of claim 13 , wherein the codon comprises the sequence GXC. 18. The cell of claim 17 , wherein the unnatural nucleobase of X is 19. The cell of claim 17 , wherein the unnatural nucleobase of X is 20. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is from Methanosarcina barkeri. 21. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is from Methanococcus jannaschii. 22. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is a pyrrolysyl tRNA synthetase. 23. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is a tyrosyl tRNA synthetase. 24. The cell of claim 1 , wherein the cell is a microorganism or bacterium. 25. The cell of claim 1 , wherein the cell is an E. coli cell.

Assignees

Inventors

Classifications

  • C12N9/93Primary

    Ligases (6) · CPC title

  • C12P21/02Primary

    having a known sequence of two or more amino acids, e.g. glutathione · CPC title

  • Pyrrolysine-tRNAPyl ligase (6.1.1.26) · CPC title

  • C12N15/11Primary

    DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

  • Stable introduction of foreign DNA into chromosome · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11834689B2 cover?
Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.
Who is the assignee on this patent?
Synthorx Inc, Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification C12N9/93. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).